There is provided a pharmaceutical agent, food, or beverage for treating or preventing a disease or condition that can be ameliorated by inhibiting serotonin reuptake, comprising a clinically-effective amount of (1S,3S)-2-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid.
本发明提供了一种药物制剂、食品或饮料,用于治疗或预防可通过抑制
血清素再摄取而改善的疾病或病症,其中包含临床有效量的(1S,3S)-2-甲基-1,2,3,4-四氢-β-咔啉-3-
羧酸。